Premium
Workshop on prostate markers
Author(s) -
Murphy Gerald P.,
Partin Alan
Publication year - 1998
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/(sici)1097-0142(19981115)83:10<2233::aid-cncr25>3.0.co;2-k
Subject(s) - medicine , prostate carcinoma , prostate , prostate specific antigen , prostate cancer , glutamate carboxypeptidase ii , oncology , prostate disease , antigen , pathology , immunology , cancer
Clinicians and scientists from Europe and the U. S. recently met to discuss new data regarding relevant markers for prostate carcinoma. These markers are of particular interest because of their potential to improve the diagnosis of early prostate carcinoma and their ability to aid in the prognostic evaluation of all stages of disease. Neuroendocrine cell markers, free prostate specific antigen (PSA), complex PSA (hK2), and prostate specific membrane antigen were evaluated. The results raise significant questions for current and future research.